Praxis Precision Medicines (PRAX) Cash & Equivalents (2022 - 2025)
Historic Cash & Equivalents for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to $149.5 million.
- Praxis Precision Medicines' Cash & Equivalents fell 1133.62% to $149.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $149.5 million, marking a year-over-year decrease of 1133.62%. This contributed to the annual value of $215.4 million for FY2024, which is 16491.02% up from last year.
- As of Q3 2025, Praxis Precision Medicines' Cash & Equivalents stood at $149.5 million, which was down 1133.62% from $157.4 million recorded in Q2 2025.
- In the past 5 years, Praxis Precision Medicines' Cash & Equivalents ranged from a high of $215.4 million in Q4 2024 and a low of $56.0 million during Q2 2022
- Moreover, its 4-year median value for Cash & Equivalents was $124.3 million (2023), whereas its average is $119.9 million.
- As far as peak fluctuations go, Praxis Precision Medicines' Cash & Equivalents skyrocketed by 16491.02% in 2024, and later crashed by 1133.62% in 2025.
- Quarter analysis of 4 years shows Praxis Precision Medicines' Cash & Equivalents stood at $61.6 million in 2022, then soared by 31.95% to $81.3 million in 2023, then soared by 164.91% to $215.4 million in 2024, then plummeted by 30.57% to $149.5 million in 2025.
- Its Cash & Equivalents was $149.5 million in Q3 2025, compared to $157.4 million in Q2 2025 and $165.6 million in Q1 2025.